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Objective: Reverse transcription quantitative real-time polymerase chain reaction is efficient for quantification of
gene expression, but the choice of reference genes is of paramount importance as it is essential for correct
interpretation of data. This is complicated by the fact that the materials often available are routinely collected
formalin-fixed, paraffin-embedded (FFPE) samples in which the mRNA is known to be highly degraded. The
purpose of this study was to investigate 22 potential reference genes in sarcoma FFPE samples and to study the
variation in expression level within different samples taken from the same tumor and between different histologic
types. Methods: Twenty-nine patients treated for sarcoma were enrolled. The samples encompassed 82 (FFPE)
specimens. Extraction of total RNA from 7-μm FFPE sections was performed using a fully automated, bead-base
RNA isolation procedure, and 22 potential reference genes were analyzed by reverse transcription quantitative real-
time polymerase chain reaction. The stability of the genes was analyzed by RealTime Statminer. The intrasamples
variation and the interclass correlation coefficients were calculated. The linear regression model was used to
calculate the degradation of the mRNA over time. Results: The quality of RNA was sufficient for analysis in 84% of
the samples. Recommended reference genes differed with histologic types. However, PPIA, SF3A1, and MRPL19
were stably expressed regardless of the histologic type included. The variation in Cq value for samples from the
same patients was similar to the variation between patients. It was possible to compensate for the time-
dependent degradation of the mRNA when normalization was made using the selected reference genes.
Conclusion: PPIA, SF3A1, and MRPL19 are suitable reference genes for normalization in gene expression studies
of FFPE samples from sarcoma regardless of the histology.
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Sarcoma is a heterogeneous group of rare tumors whose resistance to
radiotherapy, chemotherapy, and molecularly targeted therapies is a
major problem in clinical practice hindering major breakthroughs in
outcome in the past decades [1].
New biological knowledge such as the discovery of the important
role played by cancer stem cells, genetics, and epigenetic changes on
resistance to treatment and eventual prognosis has shown that factors
other than those traditionally measured and tested can be detrimental
to treatment outcome. Gene expression analysis is increasingly
important to understand tumor initiation/progression, giving insight
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processes involved in tumorigenesis.
Reverse transcription quantitative real-time polymerase chain
reaction (RT-qPCR) is a powerful technique which can detect low
levels of mRNA. RT-qPCR is a fast and efficient technique for
quantification of the gene expression levels [2]. However, the results
are dependent on appropriate selection of normalization factors to
account for errors and differences generated by the multistep process.
Variables such as the differences between tissues in overall
transcriptional activity need to be controlled in gene expression
analysis. The use of internal control (reference) genes is the most
commonly used method. Reference genes should be constitutively
expressed and should have a stable expression under the experimental
conditions and tissue preparation techniques. The expression of
internal reference genes varies significantly under different experi-
mental conditions. Therefore, erroneous information could be
generated if normalization is based on genes that themselves are
regulated or affected by the preparation of tissue samples [3,4].
The clinical material often available for analysis from sarcoma
patients is routinely collected formalin-fixed, paraffin-embedded
(FFPE) samples processed under different conditions. Factors such as
time to fixation, fixation time, and others may contribute to variations
in gene expression levels by introducing RNA degradation [5,6]. It is
also well known that mRNA from FFPE tissue specimens is poorly
preserved and highly degraded [7]. In rare cancer types such as
sarcoma, the FFPE tissue samples are indispensable and invaluable
resources for studying gene expression levels. Other studies have
shown that using RNA from FFPE tissue samples is feasible [8–10].
Due to these issues, candidate reference genes must be validated in
defined experimental conditions. The purpose of the study was to
investigate 22 potential reference genes in FFPE tissue samples withTable 1. Sample Characteristics
Patient Histology Time Age
(No.) (year of biopsy)
1 Ewing 1999 24
2 Fibrosarcoma 1994 36
3 Leiomyosarcoma 1995 66
4 Leiomyosarcoma 1994 53
5 Liposarcoma 1999 69
6 Liposarcoma 2001 54
7 Liposarcoma 1993 80
8 Liposarcoma 1994 45
9 Liposarcoma 2000 64
10 Liposarcoma 2001 56
11 Liposarcoma 1994 77
12 Liposarcoma 1995 77
13 PUS 1993 74
14 PUS 1998 64
15 PUS 1993 73
16 PUS 1993 53
17 PUS 1994 76
18 PUS 1993 67
19 PUS 1993 64
20 PUS 1993 43
21 PUS 1993 87
22 PUS 1993 63
23 PUS 1993 81
23 Osteosarcoma 1994 54
24 MPNST 2000 51
25 MPNST 1998 37
26 Synovial sarcoma 1998 50
27 Synovial sarcoma 1991 45
29 Synovial sarcoma 1997 33
* The following genes were not included in the analysis: HMBS, HPRT1, TFRC, and PSMC4.various histology types of sarcoma and to investigate the variation
within different samples taken from the same tumor.
Material and Methods
Patient Samples
Twenty-nine patients treated for sarcoma at the Sarcoma Centre of
Aarhus University Hospital between 1991 and 2001 were enrolled in
this study. The selected patients’ characteristics are presented in
Table 1. The tissue samples represented surgical specimens, and for
most patients, more than one tissue sample from different locations in
the tumor was analyzed. The tissue samples encompassed 82 FFPE
tissue samples (between 1 and 6 per patients, with a median of 3
samples per patient) of different histologic types: pleomorphic
undifferentiated sarcoma (PUS; n = 10), liposarcoma (n = 8),
leiomyosarcoma (n = 2), malignant peripheral nerve sheath tumor
(MPNST, n = 2), synovial sarcoma (n = 2), osteosarcoma (n = 1),
Ewing (n = 1), and fibrosarcoma (n = 1). No information about the
time from sampling to fixation or the fixation time was available. The
tumor tissue samples were chosen based on the pathology report. The
tissue sample was excluded from the analysis if more than one gene
was not detectable or if the sample was 100% necrotic. One patient
was excluded because of 100% normal tissue in all samples. This
resulted in excluding 18 samples, and the analysis was done on 64
tissue samples from 25 patients (Table 1).
RNA Extraction and cDNA Synthesis
Extraction of total RNA from 7-μm FFPE sections from tissue
samples and empty paraffin blocks was performed by the Tissue
Preparation System with VERSANT Tissue Preparation Reagents.
This is a fully automated, bead-based RNA isolation methodSamples No. of Genes % Tumor % Necrosis
(No.) not detected *
2 0/0 90/90 0/0
1 0 100 0
3 0/0/0 100/100/100 0/0/0
3 0/1/6 100/90/80 0/0/20
3 0/0/0 30/30/0 60/60/100
3 0/0/0 80/80/100 0/0/0
3 0/0/0 100/20/30 0/80/70
3 8/0/8 20/100/100 80/0/0
3 0/0/0 0/0/0 0/0/0
3 0/0/0 50/50/60 0/0/30
3 0/1/0 90/80/40 10/20/60
3 0/0/0 100/90/100 0/10/0
3 19/0/1 0/0/0 100/80/0
3 0/0/0 20/20/60 0/0/0
3 0/0/0 100/100/60 0/0/0
1 0 90 10
4 0/0/0/0 85/70/70/70 10/0/20/10
3 0/0/0 75/30/40 30/60/60
6 6/0/0/0/0/0 100/50/100/95/100 0/50/0/0/0
3 0/0/0 80/60/0 20/40/0
2 0/1 60/40 30/50
3 0/0/0 100/100/90 0/0/10
3 15/6/17 10/10/10 90/90/90
2 0/0 80/90 0/0
3 0/0/8 90/100/0 10/0/0
3 0/0/0 90/80/20 0/10/80
3 0/0/0 95/60/60 5/0/10
3 0/0/0 100/60/70 0/40/30
1 9 90
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elsewhere [11]. Previous data with similar FFPE tissue samples have
shown that although the RNA integrity number values are very low
due to highly degraded RNA [7], it is still possible to obtain
reproducible qPCR data. Furthermore, the RNA quantity could not
be measured on a spectrophotometer because of the elution buffer
from the VERSANT Tissue preparation reagents kit (Siemens) which
absorbs light at the same wavelength as RNA. However, high-quality
and reproducible qPCR data can be obtained using short amplicons
(b100 bp) and a preamplification step [7,12]. The data from the RT-
qPCR were used as an internal quality control, with the quantity and
the quality of the RNA reflected in the Cq values of the stable
expressed reference genes. The extraction included DNase I treatment
to remove potential genomic DNA according to the manufacturer’s
protocol. cDNA was generated using the High Capacity cDNA
Archive Kit (Applied Biosystems [ABI], Foster City, CA) according to
the manufacturer’s protocol. The RNA samples were used within
2 months after preparation and were stored at −70°C until use. The
cDNA were analyzed immediately after preparation.
Primers and RT- qRCR
Before RT-qPCR, 10 cycles of preamplification were performed
according to the manufacturer’s protocol (Taqman Preamp Master Mix,
ABI) with modification as described elsewhere [7]. The reference genes
were selected from commonly used reference genes and from the literature
with the following search terms using the PubMed database: (“PCR” and
“reference” and “sarcoma”) or (“genes”[Mesh] and “Sarcoma”[Mesh] and
“reference”) or (“aPCR”[Mesh] and “Sarcoma”[Mesh]) or (“qPCR” and
“sarcoma”[Mesh]) or (“qPCR” and reference” and “genes”) or (“qPCR”
and “housekeeping” and “genes”). A further selection was done by
excluding all non–cancer-related publications. The reference genes
selected for further analysis are shown in Table 2. Assays were selected
with an exon junction spanning probe and if possible purchased from
ABI. For CALM2 and RPL37A, no ABI assays were suitable, and
specifically designed assays were supplied byDNATechnology (Aarhus,able 2. Summary of the Candidate Reference Genes and Function
ene Symbol Gene Name Gene Function Assay ID * Amplicon
CTB Actin, βActin, β Structural protein (cytoskeletal) Hs01060665_g1 63
CTR3 ARP3 actin-related protin 3 homolog Major constituent of the ARP2/3 complex Hs01029161_m1 72
2M β-2-microglobulin Beta-chain of major histocompatibility complex class I molecules Hs00984230_m1 80
ALM2 Calmodulin 2 Calcium-binding messenger protein ** 72
HCHD1 Coiled-coil-helix domain containing 1 Nuclear protein Hs00415054_m1 79
APDH Glyceraldehyde-3-phosphate dehydrogenase Glycolysis Hs02758991_g1 97
USB Glucuronidase, β Degradation of dermatan and keratan sulfates Part no 4333767F 81
MBS Hydroxymethylbilane synthase Heme synthesis, porphyrin metabolism Hs00609293_g1 62
PRT1 Hypozanthine phosphoribosyl transferase Purine salvage Part no 4333768T 100
O8 Importin 8 Nuclear protein import Hs00183533_m1 71
RPL19 Mitochondrial ribosomal protein L19 Component of the large ribosomal subunit Hs00608519_m1 72
DFIP1 Nedd4 family interacting protein 1 Integral Golgi membrane proteins Hs00228968_m1 67
OLR2A RNA polymerase II Catalyzes the RNA synthesis Hs01108291_m1 86
PIA Peptidylpropyl isomerase A cis-trans isomerization of proline imidic peptid bonds Part no. 4333763F 98
SMC4 Proteasome 26S subunit ATP-dependent degradation of ubiquitinated protien Hs00197826_m1 83
UM1 Pumilio homolog 1 translational regulation of mRNA Hs00472881_m1 77
PL37A Ribosomal protein L37a Protein synthesis *** 65
PLP0 Ribosomal protein, large, P0 Structural protein of ribosomes Hs00420895_gH 76
NA18s 18S ribosomal RNA Structural RNA for the small component of ribosomes Hs03928990_g1 61
F3A1 Splicing factor 3a, subunit 1 pre-mRNA splicing Hs01066327_m1 64
BP TATA box binding protin RNA prolymerase II transcription factor Hs00427621_m1 65
FRC Transferrin receptor Uptake of iron Hs00951083_m1 66
* Supplied by ABI.
** Primer (forward/reverse) GAGCGAGCTGAGTGGTTGTG/AGTCAGTTGGTCAGCCATGCT probe: TCGCGTCTCGGAAACCGGAGC, supplied by DNA Technology.
*** Primer (forward/reverse) TGTGGTTCCTGCATGAAGACA/GTGACAGCGGAAGTGGTATTGTAC probe:TGGCTGGCGGTGCCTGGA, supplied by DNA Technology.T
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(assay numbers or primers and probes are shown in Table 2). The
experiment was performed on an ABI PRISM 7900HT in 384-well
plates assembled by Biomek 3000 (Beckman Coulter). The qPCR
reaction consisted of 3 μl cDNA, 0.75 μl 20× TaqMan Assay, and
7.5 μl of Taqman Gene Expression Mastermix (ABI), in a total volume
of 15μl. The cDNAwas not quantified as we used the results of the RT-
qPCR as quality control. The experiment was initiated by one cycle at
95°C for 10 minutes, followed by 40 cycles of 95°C for 15 seconds and
60°C for 1 minute. Samples were loaded in duplicate along with
negative controls. Negative controls consisted of both samples from
empty paraffin blokes and no template controls. All negative controls
where run on each plate. No signal was detected. Positive controls were
included consisting of pooled RNA from cell lines. Cq values with a
standard deviation above 0.3 between duplicated samples were
dismissed, and the RT-qPCR were repeated.
Data Analysis and Statistics
The stability of the reference genes was analyzed using the RealTime
Statminer (Integromics, Madison,WI), version 20. Cq values above 35
were regarded as below detection limit. Thresholds were set manually in
the SDS2.1 software. The GeNorm algorithm calculates an internal
control gene-stability measure M. A low value of M means a high
relative stability. GeNorm includes the top-ranked genes as reference
genes, and the recommended number of reference genes depends on the
pairwise variation as described by Vandesompele et al. A pairwise
variation under 0.15 was chosen as previously described [13].
NormFinder collects two genes as reference genes and not necessarily
the gene with the best stability scores. The algorithm for NormFinder
has been described by Andersen et al. [14]. Table 3 shows the
M score calculated by GeNorm and the stability score calculated by
NormFinder. For both algorithms, the genes were ranked, and a
total rank was established based on all the different analysis entities
when analyzing all tissue together, liposarcoma and MHF tissue
samples together, and liposarcoma tissue samples and PUS tissue
Table 3. Ranking of the Genes by Tissue Type and Algorithm
Gene Symbol All Tissue Samples Liposarcoma and MFH Together Liposarcoma MFH Overall
M Value * Rank S Score Rank M Value Rank S Score Rank M Value Rank S Score Rank M Value Rank S Score Rank Rank
ACTB 0.89 7 0.39 5 0.89 11 0.22 11 0.86 13 0.49 12 0.47 1 0.36 7 8
ACTR3 1.41 14 0.55 14 0.99 14 0.18 8 0.86 12 0.43 10 0.76 10 0.40 11 12
B2M 1.41 15 0.68 18 1.22 16 0.22 13 1.24 17 0.81 18 1.11 19 0.61 19 17
CALM2 0.80 3 0.25 1 0.79 5 0.13 3 0.67 6 0.38 6 0.71 9 0.40 10 4
CHCHD1 0.83 5 0.41 7 0.80 6 0.16 5 0.63 5 0.40 8 0.72 8 0.34 4 6
GAPDH 1.61 17 0.61 16 1.50 18 0.29 17 1.58 18 0.95 19 1.07 17 0.48 14 18
GUSB 1.70 18 0.49 11 0.88 10 0.19 10 2.14 19 0.76 17 0.95 15 0.54 16 14
IPO8 0.81 4 0.49 12 0.75 4 0.11 1 0.61 4 0.25 2 0.85 12 0.50 15 7
MRPL19 * 0.75 1 0.34 4 0.81 7 0.14 4 0.39 1 0.36 4 0.55 3 0.29 2 1
NDFIP1 1.28 13 0.44 8 1.36 17 0.31 18 1.20 16 0.65 16 0.69 7 0.30 3 13
POLR2A 1.18 11 0.49 10 0.87 9 0.13 2 0.82 11 0.47 11 0.91 14 0.44 13 11
PPIA * 0.86 6 0.29 2 0.63 1 0.17 7 0.73 8 0.40 7 0.64 4 0.36 6 3
PUM1 1.55 16 0.60 15 0.94 12 0.22 12 0.93 14 0.57 15 0.98 16 0.57 17 15
RPL37A 1.08 9 0.49 13 0.97 13 0.28 15 0.39 2 0.37 5 0.78 11 0.38 9 10
RPLP0 1.00 8 0.46 9 0.87 8 0.17 6 0.79 10 0.42 9 0.88 13 0.43 12 9
rRNA18s 1.21 12 0.64 17 1.15 15 0.28 16 1.00 15 0.56 14 1.07 18 0.61 18 16
SF3A1 * 1.16 10 0.39 6 0.63 2 0.18 9 0.64 3 0.23 1 0.47 2 0.27 1 2
TBP 0.75 2 0.33 3 0.73 3 0.25 14 0.71 7 0.35 3 0.66 6 0.37 8 5
The bold and underlined values are the recommended reference genes by the two different algorithms GeNorm and NormFinder when analyzing all tissue samples, liposarcoma and PUS together, and
liposarcoma and PUS separately. From these results, an overall ranking was determined, and the three best ranking genes were selected as reference genes.
* When considering the total rank of the different types analyzed, these 3 genes have the lowest score.
690 Reference Gene Analysis of FFPE Sarcoma Samples Aggerholm-Pedersen et al. Translational Oncology Vol. 7, No. 6, 2014samples as separate groups. The three best ranked genes were used as
reference genes.
ΔCq values were generated by normalizing the geometric mean of
the most stable reference genes. ΔCq values were calculated in
RealTime Statminer version 20.
The intrasamples variation (the standard deviation of single
measurements) was calculated and reported with a 95% confidence
interval (CI) for each gene. The highest and lowest ΔCq values were
used, and only patients with two or more samples were included. The
interclass correlation coefficients were calculated and reported with a
95% CI for each gene to determine the intra and inter variability from
each sample. The assumption of the error following a normal
distribution was met for all three genes analyzed. The linear regression
model was used to calculate the degradation of the mRNA over time.
All statistical analysis was performed by using Stata version 12.
Ethics
The study has been approved by the Ethics Committee of
Denmark (no. 1-10-72-233-12) and the Danish Agency of Data
Protection (no. 2012-41-0657).
Results
Of the 82 tissue samples from 29 sarcoma patients, 18 tissue samples
were excluded due to more than one missing value in the qPCR
analysis. This meant that the potential reference genes could be
analyzed in 78% of all tissue samples (64 samples from 25 patients).
The Cq value for PSMC4, HPRT1, HMBS, and TFRC were below
the detection limit in 15%, 22%, 23%, and 54% of the analyzed
tissue samples, respectively. These genes were therefore excluded from
the analysis. Table 1 shows the different histologic types and year of
biopsy, age of the patient, how many samples from each tumor were
collected, and the number of genes not detected in each tissue
samples. The last two columns show the percentage of tumor tissue
and necrotic tissue in each sample.
To establish which reference was the most stable, the 18
detectable reference genes were analyzed using both the GeNorm
and NormFinder algorithm. When all tissue samples were analyzed
together, the reference genes found to be the most stable genes wereMRPL19, CALM2 IPO8, TBP and TBP, PPIA for GeNorm and
NormFinder, respectively. When analyzing liposarcoma and PUS
tissue samples together, the most stable reference genes were TBP,
PPIA, SF3A1, IPO8 and TBP, RPLPO for GeNorm and
NormFinder, respectively. When analyzing PUS tissue samples
alone, the most stable genes were SF3A1, ACTB, MRPL19 and
NDFIP1, SF3A1 for GeNorm and NormFinder, respectively.
When analyzing liposarcoma tissue samples alone, the most stable
reference genes were SF3A1 RPL7A, MRPL19 and PPIA, RPL37A
GeNorm and NormFinder, respectively. The ranking of the genes is
shown in Table 3, and the top-ranking genes, regardless of the
algorithm used and tissue included in the analysis, were MRPL19,
PPIA, and SF3A1. The mean Cq value for these three reference
genes was 26.9 (95% CI: 26.7 to 27.1). The least stable genes
regardless of tissue type and algorithm were B2M, GAPDH, GUSB,
PUM1, and rRNA18s.
The ΔCq values were calculated using the most stable genes
MRPL19, PPIA, and SF3A1 as reference genes for the same three
genes to establish whether or not there was a difference in the ΔCq
value between different tissue samples taken from the same patient
(Figure 1). The measurement error or the standard deviation of single
measurements (ΔCq value) was 0.61 (95% CI: 0.47 to 0.86), 0.33
(95% CI: 0.26 to 0.47), and 0.44 (95% CI: 0.34 to 0.61) for PPIA,
SF3A1, and MRPL19, respectively. The intraclass correlation
coefficients were calculated to find how strongly samples from the
same patients resembled each other and show the proportion of total
variance within each patient. The intraclass correlation coefficients
were 0.57 (95% CI: 0.34 to 0.79), 0.61 (95% CI: 0.40 to 0.82), and
0.47 (95% CI: 0.21 to 0.72) for PPIA, SF3A1, and MRPL19,
respectively. Supplementary Figure 1 shows the ΔCq value for each
patient against sample number. Each line represents one patient,
according to the investigated genes and histologic type of the patients.
Supplementary Figure 2 shows the Bland-Altman plot of difference
versus average, comparing the highest and lowest ΔCq value in each
patient. When analyzing liposarcoma alone, the measurement error of
the ΔCq value for each individual was 0.38 (95% CI: 0.25 to 0.78),
0.25 (95% CI: 0.17 to 0.52), and 0.29 (95% CI: 0.19 to 0.58) for
PPIA, SF3A1, and MRPL19, respectively, and for PUS, 0.76 (95%
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Figure 1. Cq value for the three most stably expressed genes for each patient. The Cq values were normalized to the geometric mean of
the same three genes. The patient numbers are represented at the y-axis. The histologic type for patient number 1 was Ewing sarcoma;
for patient number 2, fibrosarcoma; for patient numbers 3 to 4, leiomyosarcoma; for patient numbers 5 to 12, liposarcoma; for patient
numbers 13 to 23, PUS; for patient number 24, osteosarcoma; for patient numbers 25 and 26, MPNST; and for patient numbers 27 to 29,
synovial sarcoma. Four patients were not included as explained in Material and Methods.
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0.41 to 1.10) for PPIA, SF3A1, and MRPL19, respectively. Figure 2
shows the variation for all potential reference genes when all samples
were normalized to the three most stable genes. The outliner values
seen for each gene represent different patients.−
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Figure 2. Median centered Cq values of the 22 studied reference
genes, normalized to the three highest-ranking reference genes. All
histologic types are represented in this figure. The number of
tissue samples for each gene is 64. The y-axis represents each
gene analyzed.The raw Cq values were used to establish the degradation rate of
the three most stable reference genes. For PPIA, SF3A1, and
MRPL19, the degradation was −0.37 Cq/year (95% CI: −0.48 to −
0.27), −0.34 (95% CI: −0.44 to −0.23), and −0.32 (95% CI: −0.43
to −0.23). There was no difference in the slope of the line P = .84.
This gives an overall half-life of the mRNA of 2.9 years (95% CI: 2.4
to 3.6) (Figure 3a). When normalization of the three most stable
genes to the geometric mean of the same three genes, the degradation
was −0.03 (95% CI: −0.09 to 0.03), 0.00 (95% CI: −0.03 to 0.03),
and 0.00 (95% CI: −0.04 to 0.03) for PPIA, SF3A1, and MRPL19,
respectively (Figure 3b).
Discussion
Few studies have addressed the issue of identifying steadily expressed
reference genes in sarcoma samples, and to the best of the authors’
knowledge, this is the first article to address the problem in FFPE tissue
samples from sarcoma patients. Reference gene selection is crucial
because it directly influences the interpretation of RT-qPCR data.
According to the Minimum Information for Publication of
Quantitative Real-time PCR experiments guidelines [15], the RNA
integrity and purity should be quantified. However, it is well known
that the mRNA from FFPE tissue samples is highly degraded and
chemical modifications occur during fixation and storage [5,6,16].
Although we could not measure the purity and integrity of mRNA in
the present study, it was still possible to quantify the expression levels
of 18 reference genes in 78% of the tissue samples. This is by itself an
important finding because, in the everyday clinic, the FFPE tissue
samples often are the only available specimens for research. Due to the
low quality of mRNA from old FFPE tissue samples, a proper choice
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Figure 3. The top figure shows the Cq value for the most stably
expressed genes, with the slope of the line representing the
degradation of the RNA/year. The bottom figure shows the Cq
value for the most stably expressed genes normalized to the
geometric mean of the same three genes according to the age for
the FFPE tissue blocks. The y-axis represents the year of diagnosis.
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reference genes is, however, also highly dependent on the tissues or
cells under investigation [17,18], and the expression level of the
reference genes can even change with different anatomical regions
[19]. In this study, we used GeNorm and NormFinder to find the
most stably expressed reference genes. However, the two methods
apply different statistical algorithms, and it was therefore not
surprising that they gave somewhat different results. Also, different
reference genes are recommended for different histologic types of
sarcoma (Table 3). For example, NDFIP1 was recommended by the
NormFinder algorithm when analyzing PUS, but this potential
reference gene was poorly ranked when analyzing liposarcoma.
Nevertheless, there was general agreement that MRPL19, PPIA, and
SF3A1 were within the 10 top-ranking genes regardless of the tissue
under investigation or algorithms used. Vandesomple et al. have
recommended at least three appropriate reference genes for
calculation of a normalization factor because of the variation in the
expression of reference genes [13], which were also used in this study.
The selected reference genes in this study have been shown to be
stable expressed in other tissues than sarcoma. In studies investigating
reference genes for RT-qPCR experiments using FFPE,MRPL19 hasalso been shown to be among the top-ranked reference genes for
FFPE samples from both breast [20] and lung cancer patients [7].
PPIA has been found to be among the most suitable reference
genes for normalization in human FFPE epithelial ovarian tissue
samples [21] and from fresh frozen tissue samples in colon cancer
[22]. SF3A1 has been found to be among the most stable genes in
fresh frozen breast cancer specimens [23].
Because reference genes stably expressed in one cancer type may be
less stably expressed in another cancer or under a different
experimental condition [3,4,17,24], we investigated both the
intraindividual variation and interindividual variation for all tissues
together and for the liposarcoma and PUS separately. These results
showed that 57%, 61%, and 47% of the variation in ΔCq values for
PPIA, SF3A1, and MRPL19, respectively, were a variation between
patients rather than within each patient, taking the effect of different
histologic types into account. This means that the variation within the
samples of each patient is not different than the variation detected
between patients, which is desirable when choosing proper reference
genes. When looking at the measurement error for all tissues and for
PUS and liposarcoma alone, the main intraindividual variation was
seen in the PUS samples.
It is important here to note that GAPDH, B2M, and rRNA18s
commonly used as reference genes in other studies were, in fact, the least
stable genes regardless of tissue type and analysis algorithms in these
FFPE tissue samples. The less stable expression of GAPDH is in
agreement with previously published results showing an eight-fold
difference in expression levels in different tissue types [3]. Another often
used reference gene,ACTB, has been shown to have a 22-fold difference
in expression levels when comparing different tissue types [3]. In our
experiments, we also found variation among different histologic types.
The total RNA is predominantly composed of rRNA and does not
always reflect mRNA content [25], which is why ribosomal RNA
might not be a good reference gene. RNA from FFPE samples is
highly degraded, nucleic acids are cross-linked to proteins, and base
modifications are introduced during the fixation process [26]. The
half-life of the mRNA was found to be 2.9 years (95% CI: 2.4 to 3.6),
which is within the range of previously published results [27]. When
normalizing the three most stable genes to the geometric mean of the
same three genes, the effect of degradation was eliminated. However,
it is important to analyze the degradation of both target genes and
reference genes to ensure the same degradation level.
It is of great importance that every research group investigating gene
expression, protein expression, or DNA uses proper reference genes.
The results will never get better than the reference genes used in the
study. The lack of proper reference gene analysis before conducting gene
expression analysis may lead to misleading conclusions and possible
undesirable clinical consequences. However, as this study also shows, it
might not be possible to exclude or include any specific set of reference
genes without testing the genes in the specific experimental setting.
In conclusion, PPIA, SF3A1, and MRPL19 are suitable reference
genes for normalization in gene expression profiling studies of FFPE
samples from primary soft tissue sarcoma. Although there may be
differences in the recommended reference genes according to the
histologic sarcoma subtype, it is possible to find reference genes that
are stably expressed regardless of the histology of the sarcoma. We
recommend that this specific set of reference genes be used and
validated in independent experimental setting.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.tranon.2014.09.012.
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